The Crabtree and Warburg effects: Do metabolite-induced regulations participate in their induction?

Biochimica et Biophysica Acta - Bioenergetics

Volumn 1857, Issue 8, 2016, Pages 1139-1146

  Hammad, Noureddine ^a,b   Rosas Lemus, Monica ^a,b,c   Uribe Carvajal, Salvador ^c   Rigoulet, Michel ^a,b   Devin, Anne ^a,b  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b CNRS   (France)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Crabtree; Glycolysis; Metabolites; Oxidative phosphorylation; Warburg

Indexed keywords

2 OXOGLUTARIC ACID; 6 PHOSPHOFRUCTOKINASE; ADENOSINE TRIPHOSPHATE; CITRIC ACID; DIOXYGENASE; FATTY ACID; FRUCTOSE 2,6 BISPHOSPHATE; GLUTAMINE; HISTONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; PENTOSE PHOSPHATE; PYRUVATE KINASE; PYRUVATE KINASE M2; RIBULOSE PHOSPHATE; UNCLASSIFIED DRUG; FRUCTOSE BISPHOSPHATE; FRUCTOSE PHOSPHATE; FRUCTOSE-1,6-DIPHOSPHATE; FRUCTOSE-6-PHOSPHATE; GLUCOSE; GLUCOSE 6 PHOSPHATE; OXYGEN;

ALLOSTERISM; AMINO ACID METABOLISM; ARTICLE; CANCER CELL; CARBOHYDRATE METABOLISM; CARCINOGENESIS; CELL ENERGY; CELL METABOLISM; CELL PROLIFERATION; CELL SURVIVAL; CELLS BY BODY ANATOMY; CITRIC ACID CYCLE; CRABTREE EFFECT; ENERGY METABOLISM; ENZYME ACTIVITY; ENZYME INACTIVATION; FATTY ACID SYNTHESIS; GLYCOLYSIS; HISTONE METHYLATION; HUMAN; HYDROXYLATION; IN VITRO STUDY; LIPOGENESIS; METABOLIC REGULATION; METABOLITE; MITOCHONDRIAL RESPIRATION; NONHUMAN; PENTOSE PHOSPHATE CYCLE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; WARBURG EFFECT; CELL RESPIRATION; DRUG EFFECTS; GENETICS; METABOLISM; NEOPLASM; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; PATHOLOGY; TUMOR CELL CULTURE;

CELL RESPIRATION; FRUCTOSEDIPHOSPHATES; FRUCTOSEPHOSPHATES; GLUCOSE; GLUCOSE-6-PHOSPHATE; GLYCOLYSIS; HUMANS; NEOPLASMS; OXIDATIVE PHOSPHORYLATION; OXYGEN; OXYGEN CONSUMPTION; TUMOR CELLS, CULTURED;

EID: 84964617172     PISSN: 00052728     EISSN: 18792650     Source Type: Journal    
DOI: 10.1016/j.bbabio.2016.03.034     Document Type: Article

References (62)

1. [1] Diaz-Ruiz, R., Rigoulet, M., Devin, A., The Warburg and Crabtree effects: on the origin of cancer cell energy metabolism and of yeast glucose repression. Biochim. Biophys. Acta 1807 (2011), 568–576.
2. [2] Crabtree, H.G., Observations on the carbohydrate metabolism of tumours. Biochem. J. 23 (1929), 536–545.
3. [3] Rodríguez-Enríquez, S., Juárez, O., Rodríguez-Zavala, J.S., Moreno-Sánchez, R., Multisite control of the Crabtree effect in ascites hepatoma cells. Eur. J. Biochem. FEBS 268 (2001), 2512–2519.
4. [4] Weinhouse, S., Glycolysis, respiration, and anomalous gene expression in experimental hepatomas: GHA Clowes memorial lecture. Cancer Res. 32 (1972), 2007–2016.
5. [5] Veech, R.L., Lawson, J.W., Cornell, N.W., Krebs, H.A., Cytosolic phosphorylation potential. J. Biol. Chem. 254 (1979), 6538–6547.
6. [6] Koobs, D.H., Phosphate mediation of the Crabtree and Pasteur effects. Science 178 (1972), 127–133.
7. [7] Sussman, I., Erecińska, M., Wilson, D.F., Regulation of cellular energy metabolism: the Crabtree effect. Biochim. Biophys. Acta 591 (1980), 209–223.
8. [8] Wojtczak, L., Teplova, V.V., Bogucka, K., Czyż, A., Makowska, A., Więckowski, M.R., Duszyński, J., Evtodienko, Y.V., Effect of glucose and deoxyglucose on the redistribution of calcium in Ehrlich ascites tumour and Zajdela hepatoma cells and its consequences for mitochondrial energetics. Eur. J. Biochem. 263 (1999), 495–501.
9. 2 +] in glucose-induced inhibition of respiration and oxidative phosphorylation in Ehrlich ascites tumour cells: a novel mechanism of the Crabtree effect. Cell Calcium 15 (1994), 439–446.
10. [10] Uribe, S., Rangel, P., Pardo, J.P., Interactions of calcium with yeast mitochondria. Cell Calcium 13 (1992), 211–217.
11. [11] Saks, V., Belikova, Y., Vasilyeva, E., Kuznetsov, A., Fontaine, E., Keriel, C., Leverve, X., Correlation between degree of rupture of outer mitochondrial membrane and changes of kinetics of regulation of respiration by ADP in permeabilized heart and liver cells. Biochem. Biophys. Res. Commun. 208 (1995), 919–926.
12. [12] Greiner, E.F., Guppy, M., Brand, K., Glucose is essential for proliferation and the glycolytic enzyme induction that provokes a transition to glycolytic energy production. J. Biol. Chem. 269 (1994), 31484–31490.
13. [13] Anmann, T., Guzun, R., Beraud, N., Pelloux, S., Kuznetsov, A.V., Kogerman, L., Kaambre, T., Sikk, P., Paju, K., Peet, N., Seppet, E., Ojeda, C., Tourneur, Y., Saks, V., Different kinetics of the regulation of respiration in permeabilized cardiomyocytes and in HL-1 cardiac cells: importance of cell structure/organization for respiration regulation. Biochim. Biophys. Acta BBA Bioenerg. 1757 (2006), 1597–1606.
14. [14] Eimre, M., Paju, K., Pelloux, S., Beraud, N., Roosimaa, M., Kadaja, L., Gruno, M., Peet, N., Orlova, E., Remmelkoor, R., Piirsoo, A., Saks, V., Seppet, E., Distinct organization of energy metabolism in HL-1 cardiac cell line and cardiomyocytes. Biochim. Biophys. Acta BBA Bioenerg. 1777 (2008), 514–524.
15. [15] Beraud, N., Pelloux, S., Usson, Y., Kuznetsov, A.V., Ronot, X., Tourneur, Y., Saks, V., Mitochondrial dynamics in heart cells: very low amplitude high frequency fluctuations in adult cardiomyocytes and flow motion in non beating Hl-1 cells. J. Bioenerg. Biomembr. 41 (2009), 195–214.
16. [16] Saks, V., Guzun, R., Timohhina, N., Tepp, K., Varikmaa, M., Monge, C., Beraud, N., Kaambre, T., Kuznetsov, A., Kadaja, L., Eimre, M., Seppet, E., Structure–function relationships in feedback regulation of energy fluxes in vivo in health and disease: mitochondrial interactosome. Biochim. Biophys. Acta BBA Bioenerg. 1797 (2010), 678–697.
17. [17] Díaz-Ruiz, R., Avéret, N., Araiza, D., Pinson, B., Uribe-Carvajal, S., Devin, A., Rigoulet, M., Mitochondrial oxidative phosphorylation is regulated by fructose 1,6-bisphosphate. A possible role in Crabtree effect induction?. J. Biol. Chem. 283 (2008), 26948–26955.
18. [18] Vexler, Z.S., Wong, A., Francisco, C., Manabat, C., Christen, S., Täuber, M., Ferriero, D.M., Gregory, G., Fructose-1,6-bisphosphate preserves intracellular glutathione and protects cortical neurons against oxidative stress. Brain Res. 960 (2003), 90–98.
19. [19] Sano, W., Watanabe, F., Tamai, H., Furuya, E., Mino, M., Beneficial effect of fructose-1,6-bisphosphate on mitochondrial function during ischemia–reperfusion of rat liver. Gastroenterology 108 (1995), 1785–1792.
20. [20] Kelleher, J.A., Chan, P.H., Chan, T.Y., Gregory, G.A., Energy metabolism in hypoxic astrocytes: protective mechanism of fructose-1,6-bisphosphate. Neurochem. Res. 20 (1995), 785–792.
21. [21] Rosas-Lemus, M., Uribe-Alvarez, C., Chiquete-Félix, N., Uribe-Carvajal, S., In Saccharomyces cerevisiae fructose-1,6-bisphosphate contributes to the Crabtree effect through closure of the mitochondrial unspecific channel. Arch. Biochem. Biophys. 555-556 (2014), 66–70.
22. [22] Calafell, R., Boada, J., Santidrian, A.F., Gil, J., Roig, T., Perales, J.C., Bermudez, J., Fructose 1,6-bisphosphate reduced TNF-alpha-induced apoptosis in galactosamine sensitized rat hepatocytes through activation of nitric oxide and cGMP production. Eur. J. Pharmacol. 610 (2009), 128–133.
23. [23] Pastorino, J.G., Shulga, N., Hoek, J.B., Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis. J. Biol. Chem. 277 (2002), 7610–7618.
24. [24] Lemeshko, V.V., VDAC electronics: 1. VDAC-hexo(gluco)kinase generator of the mitochondrial outer membrane potential. Biochim. Biophys. Acta 1838 (2014), 1362–1371.
25. [25] Nutt, L.K., The Xenopus oocyte: a model for studying the metabolic regulation of cancer cell death. Semin. Cell Dev. Biol. 23 (2012), 412–418.
26. [26] Warburg, O., On the origin of cancer cells. Science 123 (1956), 309–314.
27. [27] Brand, K., Aerobic glycolysis by proliferating cells: protection against oxidative stress at the expense of energy yield. J. Bioenerg. Biomembr. 29 (1997), 355–364.
28. [28] Gatenby, R.A., Gillies, R.J., Why do cancers have high aerobic glycolysis?. Nat. Rev. Cancer 4 (2004), 891–899.
29. [29] Moreno-Sánchez, R., Rodríguez-Enríquez, S., Marín-Hernández, A., Saavedra, E., Energy metabolism in tumor cells. FEBS J. 274 (2007), 1393–1418.
30. [30] Guppy, M., Leedman, P., Zu, X., Russell, V., Contribution by different fuels and metabolic pathways to the total ATP turnover of proliferating MCF-7 breast cancer cells. Biochem. J. 364 (2002), 309–315.
31. [31] Rodríguez-Enríquez, S., Vital-González, P.A., Flores-Rodríguez, F.L., Marín-Hernández, A., Ruiz-Azuara, L., Moreno-Sánchez, R., Control of cellular proliferation by modulation of oxidative phosphorylation in human and rodent fast-growing tumor cells. Toxicol. Appl. Pharmacol. 215 (2006), 208–217.
32. [32] Martin, M., Beauvoit, B., Voisin, P.J., Canioni, P., Guérin, B., Rigoulet, M., Energetic and morphological plasticity of C6 glioma cells grown on 3-D support; effect of transient glutamine deprivation. J. Bioenerg. Biomembr. 30 (1998), 565–578.
33. [33] Pasdois, P., Deveaud, C., Voisin, P., Bouchaud, V., Rigoulet, M., Beauvoit, B., Contribution of the phosphorylable complex I in the growth phase-dependent respiration of C6 glioma cells in vitro. J. Bioenerg. Biomembr. 35 (2003), 439–450.
34. [34] Rodríguez-Enríquez, S., Gallardo-Pérez, J.C., Avilés-Salas, A., Marín-Hernández, A., Carreño-Fuentes, L., Maldonado-Lagunas, V., Moreno-Sánchez, R., Energy metabolism transition in multi-cellular human tumor spheroids. J. Cell. Physiol. 216 (2008), 189–197.
35. [35] Smolková, K., Bellance, N., Scandurra, F., Génot, E., Gnaiger, E., Plecitá-Hlavatá, L., Ježek, P., Rossignol, R., Mitochondrial bioenergetic adaptations of breast cancer cells to aglycemia and hypoxia. J. Bioenerg. Biomembr. 42 (2010), 55–67.
36. [36] Rossignol, R., Gilkerson, R., Aggeler, R., Yamagata, K., Remington, S.J., Capaldi, R.A., Energy substrate modulates mitochondrial structure and oxidative capacity in cancer cells. Cancer Res. 64 (2004), 985–993.
37. [37] Yang, C., Ko, B., Hensley, C.T., Jiang, L., Wasti, A.T., Kim, J., Sudderth, J., Calvaruso, M.A., Lumata, L., Mitsche, M., Rutter, J., Merritt, M.E., DeBerardinis, R.J., Glutamine oxidation maintains the TCA cycle and cell survival during impaired mitochondrial pyruvate transport. Mol. Cell 56 (2014), 414–424.
38. [38] DeBerardinis, R.J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., Thompson, C.B., Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc. Natl. Acad. Sci. U. S. A. 104 (2007), 19345–19350.
39. [39] Christofk, H.R., Vander Heiden, M.G., Harris, M.H., Ramanathan, A., Gerszten, R.E., Wei, R., Fleming, M.D., Schreiber, S.L., Cantley, L.C., The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 452 (2008), 230–233.
40. [40] Herzig, S., Raemy, E., Montessuit, S., Veuthey, J.-L., Zamboni, N., Westermann, B., Kunji, E.R.S., Martinou, J.-C., Identification and functional expression of the mitochondrial pyruvate carrier. Science 337 (2012), 93–96.
41. [41] Bricker, D.K., Taylor, E.B., Schell, J.C., Orsak, T., Boutron, A., Chen, Y.-C., Cox, J.E., Cardon, C.M., Van Vranken, J.G., Dephoure, N., Redin, C., Boudina, S., Gygi, S.P., Brivet, M., Thummel, C.S., Rutter, J., A mitochondrial pyruvate carrier required for pyruvate uptake in yeast, Drosophila, and humans. Science 337 (2012), 96–100.
42. [42] Gui, D.Y., Lewis, C.A., Vander Heiden, M.G., Allosteric regulation of PKM2 allows cellular adaptation to different physiological states. Sci. Signal., 6, 2013, pe7.
43. [43] Anastasiou, D., Yu, Y., Israelsen, W.J., Jiang, J.-K., Boxer, M.B., Hong, B.S., Tempel, W., Dimov, S., Shen, M., Jha, A., Yang, H., Mattaini, K.R., Metallo, C.M., Fiske, B.P., Courtney, K.D., Malstrom, S., Khan, T.M., Kung, C., Skoumbourdis, A.P., Veith, H., Southall, N., Walsh, M.J., Brimacombe, K.R., Leister, W., Lunt, S.Y., Johnson, Z.R., Yen, K.E., Kunii, K., Davidson, S.M., Christofk, H.R., Austin, C.P., Inglese, J., Harris, M.H., Asara, J.M., Stephanopoulos, G., Salituro, F.G., Jin, S., Dang, L., Auld, D.S., Park, H.-W., Cantley, L.C., Thomas, C.J., Vander Heiden, M.G., Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis. Nat. Chem. Biol. 8 (2012), 839–847.
44. [44] Cortes-Cros, M., Hemmerlin, C., Ferretti, S., Zhang, J., Gounarides, J.S., Yin, H., Muller, A., Haberkorn, A., Chene, P., Sellers, W.R., Hofmann, F., M2 isoform of pyruvate kinase is dispensable for tumor maintenance and growth. Proc. Natl. Acad. Sci. 110 (2013), 489–494.
45. [45] Li, Z., Yang, P., Li, Z., The multifaceted regulation and functions of PKM2 in tumor progression. Biochim. Biophys. Acta 1846 (2014), 285–296.
46. [46] De Koning, T.J., Snell, K., Duran, M., Berger, R., Poll-The, B.-T., Surtees, R., L-serine in disease and development. Biochem. J. 371 (2003), 653–661.
47. [47] Chaneton, B., Hillmann, P., Zheng, L., Martin, A.C.L., Maddocks, O.D.K., Chokkathukalam, A., Coyle, J.E., Jankevics, A., Holding, F.P., Vousden, K.H., Frezza, C., O'Reilly, M., Gottlieb, E., Serine is a natural ligand and allosteric activator of pyruvate kinase M2. Nature 491 (2012), 458–462.
48. [48] Keller, K.E., Tan, I.S., Lee, Y.-S., SAICAR stimulates pyruvate kinase isoform M2 and promotes cancer cell survival in glucose-limited conditions. Science 338 (2012), 1069–1072.
49. [49] Lin, R., Elf, S., Shan, C., Kang, H.-B., Ji, Q., Zhou, L., Hitosugi, T., Zhang, L., Zhang, S., Seo, J.H., Xie, J., Tucker, M., Gu, T.-L., Sudderth, J., Jiang, L., Mitsche, M., DeBerardinis, R.J., Wu, S., Li, Y., Mao, H., Chen, P.R., Wang, D., Chen, G.Z., Hurwitz, S.J., Lonial, S., Arellano, M.L., Khoury, H.J., Khuri, F.R., Lee, B.H., Lei, Q., Brat, D.J., Ye, K., Boggon, T.J., He, C., Kang, S., Fan, J., Chen, J., 6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling. Nat. Cell Biol. 17 (2015), 1484–1496.
50. [50] Sukhatme, V.P., Chan, B., Glycolytic cancer cells lacking 6-phosphogluconate dehydrogenase metabolize glucose to induce senescence. FEBS Lett. 586 (2012), 2389–2395.
51. [51] Moreno-Sánchez, R., Marín-Hernández, A., Gallardo-Pérez, J.C., Quezada, H., Encalada, R., Rodríguez-Enríquez, S., Saavedra, E., Phosphofructokinase type 1 kinetics, isoform expression, and gene polymorphisms in cancer cells. J. Cell. Biochem. 113 (2012), 1692–1703.
52. [52] Staal, G.E., Kalff, A., Heesbeen, E.C., van Veelen, C.W., Rijksen, G., Subunit composition, regulatory properties, and phosphorylation of phosphofructokinase from human gliomas. Cancer Res. 47 (1987), 5047–5051.
53. [53] Šmerc, A., Sodja, E., Legiša, M., Posttranslational modification of 6-phosphofructo-1-kinase as an important feature of cancer metabolism. PLoS One, 6, 2011, e19645.
54. [54] Marín-Hernández, A., Rodríguez-Enríquez, S., Vital-González, P.A., Flores-Rodríguez, F.L., Macías-Silva, M., Sosa-Garrocho, M., Moreno-Sánchez, R., Determining and understanding the control of glycolysis in fast-growth tumor cells. FEBS J. 273 (2006), 1975–1988.
55. [55] Marín-Hernández, A., Gallardo-Pérez, J.C., Rodríguez-Enríquez, S., Encalada, R., Moreno-Sánchez, R., Saavedra, E., Modeling cancer glycolysis. Biochim. Biophys. Acta BBA Bioenerg. 1807 (2011), 755–767.
56. [56] Maxwell, P.H., Pugh, C.W., Ratcliffe, P.J., Activation of the HIF pathway in cancer. Curr. Opin. Genet. Dev. 11 (2001), 293–299.
57. 2 tension. Proc. Natl. Acad. Sci. U. S. A. 92 (1995), 5510–5514.
58. [58] Jiang, B.H., Rue, E., Wang, G.L., Roe, R., Semenza, G.L., Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J. Biol. Chem. 271 (1996), 17771–17778.
59. [59] Dang, L., White, D.W., Gross, S., Bennett, B.D., Bittinger, M.A., Driggers, E.M., Fantin, V.R., Jang, H.G., Jin, S., Keenan, M.C., Marks, K.M., Prins, R.M., Ward, P.S., Yen, K.E., Liau, L.M., Rabinowitz, J.D., Cantley, L.C., Thompson, C.B., Vander Heiden, M.G., Su, S.M., Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462 (2009), 739–744.
60. [60] Selak, M.A., Armour, S.M., MacKenzie, E.D., Boulahbel, H., Watson, D.G., Mansfield, K.D., Pan, Y., Simon, M.C., Thompson, C.B., Gottlieb, E., Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell 7 (2005), 77–85.
61. [61] Xu, W., Yang, H., Liu, Y., Yang, Y., Wang, P., Kim, S.-H., Ito, S., Yang, C., Wang, P., Xiao, M.-T., Liu, L., Jiang, W., Liu, J., Zhang, J., Wang, B., Frye, S., Zhang, Y., Xu, Y., Lei, Q., Guan, K.-L., Zhao, S., Xiong, Y., Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases. Cancer Cell 19 (2011), 17–30.
62. [62] Salminen, A., Kauppinen, A., Hiltunen, M., Kaarniranta, K., Krebs cycle intermediates regulate DNA and histone methylation: epigenetic impact on the aging process. Ageing Res. Rev. 16 (2014), 45–65.